Main Session
Sep
28
QP 09 - Fewer Fractions, Greater Precision: Innovations in Prostate SBRT
1051 - The ART of SABR: A Randomized Phase II Trial of Near "Margin-less" Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer: Two vs. Five Fractions
Presenter(s)
Mark Waddle, MD - Mayo Clinic Rochester, Rochester, MN